"Detailed Analysis of Executive Summary Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market Size and Share
CAGR Value
The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period.
An international Dual GIP/ GLP-1...
"Key Drivers Impacting Executive Summary Lipase Inhibitors Obesity Drugs Market Size and Share
The global lipase inhibitors obesity drugs market size was valued at USD 1.21 billion in 2024 and is expected to reach USD 3.61 billion by 2032, at a CAGR of 14.68% during the forecast period
The credible Lipase Inhibitors Obesity Drugs Marketreport comprises of various segments...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt